A clinical evaluation of flurazepam.
D000284:Administration, Oral; D001552:Benzazepines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D002214:Capsules; D002986:Clinical Trials as Topic; D005021:Ethylamines / Q000009:adverse effects / Q000627:therapeutic use; D005069:Evaluation Studies as Topic; D005260:Female; D005461:Fluorine / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D012631:Secobarbital / Q000008:administration & dosage / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000188:drug therapy*
D001552:Benzazepines; D002214:Capsules; D005021:Ethylamines; D006993:Hypnotics and Sedatives; D010919:Placebos; D012631:Secobarbital; D005461:Fluorine